cbdMD Continues Exclusive CBD Marketing Partnership with Bellator MMA
July 23 2020 - 7:30AM
Business Wire
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”),
one of the leading, and most highly trusted and recognized,
cannabidiol (CBD) brands, announced today that it is extending its
category-exclusive Official CBD marketing partnership with Bellator
MMA, a wholly owned subsidiary of ViacomCBS. As part of the
agreement, the cbdMD brand will be prominently featured on the mat
at all Bellator MMA fights and throughout all Bellator MMA social
media content.
“cbdMD has proven to be the trusted CBD brand amongst many of
the leading Bellator MMA fighters. We are excited to help cbdMD
grow its brand awareness among our global audience. With the onset
of additional advertisement opportunities, we can generate
significant brand awareness to help deliver increased sales
conversion for the brand,” said Scott Coker, President of Bellator
MMA.
Beginning July 24th, live on Paramount Network, Bellator 242:
Bandejas vs. Pettis will headline the return of Bellator MMA and
cbdMD will be prominently displayed. Bellator MMA, a leading mixed
martial arts organization featuring the best fighters in the world,
is broadcast to nearly one billion people in over 160 countries. In
the U.S., Bellator can be seen on Paramount Network and DAZN, the
world's first truly dedicated LIVE sports streaming service.
About cbdMD, Inc.
cbdMD, Inc. is a nationally recognized consumer cannabidiol
(CBD) brand whose current products include CBD tinctures, CBD
capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet
products. cbdMD is also a proud partner of Bellator MMA and Life
Time, Inc., and has one of the largest rosters of professional
sports athletes who are part of “Team cbdMD.” To learn more about
cbdMD and our comprehensive line of over 100 SKUs of U.S. produced,
Non-THC1 CBD products, please visit www.cbdMD.com, follow cbdMD on
Instagram and Facebook, or visit one of the 6,000 retail outlets
that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict and could cause actual results to differ materially from
those expressed or forecasted in the forward-looking statements,
including, without limitation, statements made with respect to the
expansion of our brand awareness and increased sales related to our
partnership with Bellator MMA, our ability to increase our market
share, our ability to expand our business and significantly
increase our revenues, our ability to effectively leverage our
brand partnerships and sponsorships, and our ability to report
profitable operations in the future. You are urged to carefully
review and consider any cautionary statements and other
disclosures, including the statements made under the heading "Risk
Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal
year ended September 30, 2019 as filed with the Securities and
Exchange Commission (the "SEC") and our other filings with the SEC.
All forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
1 Non-THC is defined as below the level of detection using
validated scientific analytical tools
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200723005123/en/
PR: cbdMD, Inc. Lauren Greene Communication Specialist
lauren.greene@cbdmd.com 843-743-9999
Investors: cbdMD, Inc. John Weston Director of Investor
Relations john.weston@cbdmd.com 704-445-3064 ext. 1103
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Mar 2024 to Apr 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2023 to Apr 2024